134 related articles for article (PubMed ID: 26703564)
1. High SPARC Expression Starting from Dysplasia, Associated with Breast Carcinoma, Is Predictive for Bone Metastasis without Enhancement of Plasma Levels.
Maroni P; Bendinelli P; Morelli D; Drago L; Luzzati A; Perrucchini G; Bonini C; Matteucci E; Desiderio MA
Int J Mol Sci; 2015 Nov; 16(12):28108-22. PubMed ID: 26703564
[TBL] [Abstract][Full Text] [Related]
2. Microenvironmental stimuli affect Endothelin-1 signaling responsible for invasiveness and osteomimicry of bone metastasis from breast cancer.
Bendinelli P; Maroni P; Matteucci E; Luzzati A; Perrucchini G; Desiderio MA
Biochim Biophys Acta; 2014 Apr; 1843(4):815-26. PubMed ID: 24373848
[TBL] [Abstract][Full Text] [Related]
3. Coordinate regulation of microenvironmental stimuli and role of methylation in bone metastasis from breast carcinoma.
Matteucci E; Maroni P; Disanza A; Bendinelli P; Desiderio MA
Biochim Biophys Acta; 2016 Jan; 1863(1):64-76. PubMed ID: 26481505
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic control of endothelin-1 axis affects invasiveness of breast carcinoma cells with bone tropism.
Matteucci E; Maroni P; Bendinelli P; Locatelli A; Desiderio MA
Exp Cell Res; 2013 Jul; 319(12):1865-1874. PubMed ID: 23660387
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients.
Nagai MA; Gerhard R; Fregnani JH; Nonogaki S; Rierger RB; Netto MM; Soares FA
Breast Cancer Res Treat; 2011 Feb; 126(1):1-14. PubMed ID: 20369286
[TBL] [Abstract][Full Text] [Related]
6. Ductal carcinoma in situ on stereotactic biopsy of suspicious breast microcalcifications: Expression of SPARC (Secreted Protein, Acidic and Rich in Cysteine) can predict postoperative invasion.
Szynglarewicz B; Kasprzak P; Donizy P; Biecek P; Halon A; Matkowski R
J Surg Oncol; 2016 Oct; 114(5):548-556. PubMed ID: 27439354
[TBL] [Abstract][Full Text] [Related]
7. Endothelin-1, Endothelin-A- and Endothelin-B-receptor expression in preinvasive and invasive breast disease.
Wülfing P; Diallo R; Kersting C; Wülfing C; Poremba C; Greb RR; Böcker W; Kiesel L
Oncol Rep; 2004 Apr; 11(4):791-6. PubMed ID: 15010874
[TBL] [Abstract][Full Text] [Related]
8. Predictive Outcomes for HER2-enriched Cancer Using Growth and Metastasis Signatures Driven By SPARC.
Güttlein LN; Benedetti LG; Fresno C; Spallanzani RG; Mansilla SF; Rotondaro C; Raffo Iraolagoitia XL; Salvatierra E; Bravo AI; Fernández EA; Gottifredi V; Zwirner NW; Llera AS; Podhajcer OL
Mol Cancer Res; 2017 Mar; 15(3):304-316. PubMed ID: 28031408
[TBL] [Abstract][Full Text] [Related]
9. Testing of a Novel Cancer Metastatic Multiplex Panel for the Detection of Bone-metastatic Disease - a Pilot Study.
Windrichova J; Fuchsova R; Kucera R; Topolcan O; Fiala O; Finek J; Slipkova D; Karlikova M; Svobodova J
Anticancer Res; 2016 Apr; 36(4):1973-8. PubMed ID: 27069189
[TBL] [Abstract][Full Text] [Related]
10. Endogenous osteonectin/SPARC/BM-40 expression inhibits MDA-MB-231 breast cancer cell metastasis.
Koblinski JE; Kaplan-Singer BR; VanOsdol SJ; Wu M; Engbring JA; Wang S; Goldsmith CM; Piper JT; Vostal JG; Harms JF; Welch DR; Kleinman HK
Cancer Res; 2005 Aug; 65(16):7370-7. PubMed ID: 16103089
[TBL] [Abstract][Full Text] [Related]
11. Selective ETAR antagonist atrasentan inhibits hypoxia-induced breast cancer cell invasion.
Smollich M; Götte M; Kersting C; Fischgräbe J; Kiesel L; Wülfing P
Breast Cancer Res Treat; 2008 Mar; 108(2):175-82. PubMed ID: 17468950
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of secreted protein acidic and rich in cystein in esophageal carcinoma and its relation to carcinoma progression.
Yamashita K; Upadhay S; Mimori K; Inoue H; Mori M
Cancer; 2003 May; 97(10):2412-9. PubMed ID: 12733139
[TBL] [Abstract][Full Text] [Related]
13. Increased levels of SPARC (osteonectin) in human breast cancer tissues and its association with clinical outcomes.
Watkins G; Douglas-Jones A; Bryce R; Mansel RE; Jiang WG
Prostaglandins Leukot Essent Fatty Acids; 2005 Apr; 72(4):267-72. PubMed ID: 15763438
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Significance of SPARC Expression in Breast Cancer: A Meta-Analysis and Bioinformatics Analysis.
Shi S; Ma HY; Han XY; Sang YZ; Yang MY; Zhang ZG
Biomed Res Int; 2022; 2022():8600419. PubMed ID: 35211625
[TBL] [Abstract][Full Text] [Related]
15. SPARC (osteonectin) in breast tumors of different histologic types and its role in the outcome of invasive ductal carcinoma.
Hsiao YH; Lien HC; Hwa HL; Kuo WH; Chang KJ; Hsieh FJ
Breast J; 2010; 16(3):305-8. PubMed ID: 20210803
[TBL] [Abstract][Full Text] [Related]
16. SPARC is associated with gastric cancer progression and poor survival of patients.
Zhao ZS; Wang YY; Chu YQ; Ye ZY; Tao HQ
Clin Cancer Res; 2010 Jan; 16(1):260-8. PubMed ID: 20028745
[TBL] [Abstract][Full Text] [Related]
17. Serum overexpression of microRNA-10b in patients with bone metastatic primary breast cancer.
Zhao FL; Hu GD; Wang XF; Zhang XH; Zhang YK; Yu ZS
J Int Med Res; 2012; 40(3):859-66. PubMed ID: 22906258
[TBL] [Abstract][Full Text] [Related]
18. Serum tumor markers in skeletal metastasis.
Tsukushi S; Katagiri H; Kataoka T; Nishida Y; Ishiguro N
Jpn J Clin Oncol; 2006 Jul; 36(7):439-44. PubMed ID: 16815865
[TBL] [Abstract][Full Text] [Related]
19. Role of endothelin A receptor in colon cancer metastasis: in vitro and in vivo evidence.
Nie S; Zhou J; Bai F; Jiang B; Chen J; Zhou J
Mol Carcinog; 2014 Feb; 53 Suppl 1():E85-91. PubMed ID: 23818293
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of nab-paclitaxel does not seem to be associated with SPARC expression in metastatic breast cancer.
Schneeweiss A; Seitz J; Smetanay K; Schuetz F; Jaeger D; Bachinger A; Zorn M; Sinn HP; Marmé F
Anticancer Res; 2014 Nov; 34(11):6609-15. PubMed ID: 25368265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
